Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL2355333

ZIMELDINE HYDROCHLORIDE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1.Cl.Cl.O

Basic Information

ChEMBL ID CHEMBL2355333
Name ZIMELDINE HYDROCHLORIDE
Phase Approved
Structure Type MOL
InChI Key WFUAVXYXJOQWAZ-GVKRCPFFSA-N
Parent Compound CHEMBL37744
Active Moiety CHEMBL37744

Known Names

H 102/09 HYDROCHLORIDE H-102/09 HYDROCHLORIDE Zimeldine dihydrochloride monohydrate Zimeldine hcl Zimeldine hydrochloride Zimelidine hydrochloride
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
6
Known Names
1
Mechanisms

Molecular Properties

317.2
MW (Da)
3.84
ALogP
2
HBA
0
HBD
16.1
PSA (Ų)
0.85
QED
0
Ro5 Violations
4
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Withdrawn
Chirality Achiral

Flags

Withdrawn
USAN Year 1977

Extended Properties

Molecular Formula C16H21BrCl2N2O
MW 408.17
Aromatic Rings 2
Heavy Atoms 19
NP-Likeness -0.70

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Serotonin (5-HT) receptor antagonist ANTAGONIST Serotonin (5-HT) receptor

Drug Warnings

Withdrawn
hepatotoxicity
Guillan-Barre Syndrome, hepatotoxicity
Country: Worldwide   Year: 1983
Withdrawn
neurotoxicity
Guillan-Barre Syndrome, hepatotoxicity
Country: Worldwide   Year: 1983
Withdrawn
hepatotoxicity
Guillan-Barre Syndrome, hepatotoxicity
Country: Worldwide   Year: 1983
Withdrawn
neurotoxicity
associated with incidences of hypersensitivity of varying severity and serious neurological side effects including the Guillain-Barre syndrome
Country: Worldwide   Year: 1983
Withdrawn
immune system toxicity
associated with incidences of hypersensitivity of varying severity and serious neurological side effects including the Guillain-Barre syndrome
Country: Worldwide   Year: 1983
Withdrawn
neurotoxicity
associated with incidences of hypersensitivity of varying severity and serious neurological side effects including the Guillain-Barre syndrome
Country: Worldwide   Year: 1983

Activity Summary

IC50 2 meas. best 5.08

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.08 4.815 8361.1 2

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL4495565 SARS-CoV-2 2
- 10.21203/rs.3.rs-23951/v1 SARS-CoV-2 1
- 10.6019/CHEMBL4495564 Replicase polyprotein 1ab 1

Data from ChEMBL 36 via Core Engine